Peng Liu, Sheng Yang, Fei Li, Xiuhua Sun, Wenyu Li, Yanyan Liu, Liang Wang, Liang Huang, Ling Qin, Wenbin Qian, Liping Su, Qingqing Cai, Xiaohong Tan, Wei Yang, Mingyu Jia, Nawei Liu, Yejiang Lou, Yue Shen, Fenlai Tan, Yuankai Shi. "ROCK-2: An ongoing open-label, randomized, multicenter phase 2 study of rocbrutinib versus investigator's choice of therapy in patients with R/R non-GCB DLBCL.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.tps7106